Menu
Batman v Superman Director Reveals Movie Scene

Batman v Superman Director Reveals Movie Scene

Xbox 360 Holiday Bundles Revealed

Xbox 360 Holiday Bundles Revealed

Caroline Wozniacki gets New Haircut because of Ann Wintour

Caroline Wozniacki gets New Haircut because of Ann Wintour

Paris Hilton just bought the Cutest and Smallest Dog

Paris Hilton just bought the Cutest and Smallest Dog

Miss America 2015: Ahead there lie even more Surprises!

Miss America 2015: Ahead there lie even more Surprises!

FDA Advisory Panel Votes In Favor Of Approval For Merck's Vorapaxar

Jan 15 2014, 5:21pm CST | by

FDA Advisory Panel Votes In Favor Of Approval For Merck's Vorapaxar
Photo Credit: Forbes
 
 

The FDA’s Cardiovascular and Renal Drugs Advisory Committee voted 10-1 in favor of approval for vorapaxar, Merck's novel thrombin receptor antagonist. The “roller coaster ride” cliché might have been invented for this drug, which was the subject of tremendous early hopes followed by major disappointments and, finally, a subsequent revival.

The committee voted in favor of the drug for use as an adjunctive therapy for the reduction of atherothrombotic events in patients with a history of myocardial infarction (MI). Panel chairperson Philip Sager said that “this drug addresses a real unmet medical need and can make a real difference for patients.”

The University of Colorado’s Mori Krantz provided the one negative vote, though in his comments he indicated that he was not entirely opposed to approval. He characterized his vote as a “formal dissent” and said that he wanted to get on the record his concerns about the large number of patients who would need to be treated with vorapaxar to prevent a single event and his fear that the bleeding complications observed in the study might be amplified in the real world.

Sanjay Kaul said that Merck ”convincingly demonstrated that the benefit exceeded the risk in the selected patient cohort. Like all development programs, it has it’s fair share of warts, but there is an unmet need in this population where we have no safe and effective therapies available. Hopefully, if approved it will be used in scenarios that optimize its benefit-risk profile.”

The panel spent much of the day wrestling with the complex questions raised by the drug’s troubled history, in which one large trial, TRACER, was stopped early due to high rates of serious bleeding and the other trial, the TRA2P trial, was redesigned in midstream. But ultimately the panel believed that TRA2P had been able to show that vorapaxar was effective in a post-MI population in which patients with a history of stroke were excluded.

Source: Forbes

You Might Also Like

Updates

Shopping Deals

 
 
 

<a href="/latest_stories/all/all/31" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

 

Comments

blog comments powered by Disqus

Latest stories

Cleveland Browns Shock New Orleans Saints in Week 2
Cleveland Browns Shock New Orleans Saints in Week 2
The Cleveland Browns stunned the New Orleans Saints, 26-24 on Sept. 14 to win their first home opener in 10 years. It was also the first win of new head coach Mike Pettine.
 
 
Ray Rice to Appeal NFL Suspension
Ray Rice to Appeal NFL Suspension
Former Baltimore Ravens running back Ray Rice will appeal his indefinite suspension from the league, per multiple reports.
 
 
The Gold Apple Watch Could Cost As Much As $1,200
The Gold Apple Watch Could Cost As Much As $1,200
The lower end sport versions will start at $349
 
 
Apple Watch will allow you to listen to music directly from your wrist
Apple Watch will allow you to listen to music directly from your wrist
The revelation comes to us directly from the CEO of Apple
 
 
 

About the Geek Mind

The “geek mind” is concerned with more than just the latest iPhone rumors, or which company will win the gaming console wars. I4U is concerned with more than just the latest photo shoot or other celebrity gossip.

The “geek mind” is concerned with life, in all its different forms and facets. The geek mind wants to know about societal and financial issues, both abroad and at home. If a Fortune 500 decides to raise their minimum wage, or any high priority news, the geek mind wants to know. The geek mind wants to know the top teams in the National Football League, or who’s likely to win the NBA Finals this coming year. The geek mind wants to know who the hottest new models are, or whether the newest blockbuster movie is worth seeing. The geek mind wants to know. The geek mind wants—needs—knowledge.

Read more about The Geek Mind.